Phase 4 N=233 Lidocaine Jelly for Pain Control During Mohs Surgery
Pain · Satisfaction, Consumer
Primary: Mean Change in Patient Perception of Pain Score — 0.5; 0.3 score on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=58 Regimen Optimization Study
Kidney Transplantation
Primary: Percentage of Clinically-suspected Biopsy-proven Acute Rejection (CSBPAR) at 6 Months — 7.7; 9.4 Percentage of participants
N/A N=22 Study of the Effects of HIRREM-SOP for Insomnia
Insomnia · Sleep Deprivation
Primary: Change in ISI Score From V1 to V3 — -7.27; -4.69 score on a scale
N/A N=204 Lymph Node Mapping in Patients With Endometrial Cancer
Endometrial Cancer
Primary: Negative Predictive Value of Sentinel Lymph Node Prediction of Metastatic Disease — 98.8 percentage of patients
N/A N=16 Inpatient Diabetes Mellitus (DM) Management With Continuous Glucose Monitoring Devices, a Pilot Study.
Diabetes Mellitus
Primary: Percentage of Time Spent in Hyperglycemia > 180 mg/dL — 35.47; 35.25 percentage of time spent > 180mg/dL
N/A N=15 Contralaterally Controlled FES for Hand Opening in Hemiplegic Cerebral Palsy
Cerebral Palsy
Primary: Change in Assisting Hands Assessment Logit Score at End of Treatment — 2.63; 4.33 Scores on a scale
N/A N=42 DilaCheck Cervical Dilation Measurement Trial
Cervical Dilation · Labor Pain · Labor Fast
Primary: Interexaminer Agreement — 9; 4 Participants
N/A N=31 The Role of Lactobacillus Reuteri in Children and Adolescents With Anorexia Nervosa
Anorexia Nervosa · Constipation
Primary: Number of Participants That Drop Out From Rome III Criteria for Constipation — 13; 10 Participants
Phase 2 N=18 Tremelimumab and Durvalumab With or Without Radiation Therapy in Patients With Relapsed Small Cell Lung Cancer
Recurrent Small Cell Lung Carcinoma
Primary: Progression Free Survival (PFS) — 2.1; 3.3 months
Phase 2 N=62 Selumetinib in Patients Receiving Pemetrexed and Platinum-based Chemotherapy in Advanced or Metastatic KRAS Wildtype or Unknown Non-Squamous NSCLC
Non-Small Cell Lung Cancer
Primary: Objective Response Rate — 6; 14; 5; 14 Participants — p=0.73
N/A N=16 Comparative Efficacy of the Masquelet Versus Titanium Mesh Cage Techniques for the Treatment of Large Long Bone Defects
Segmental Long Bone Defects
Primary: Number of Participants With Defect Healing - Plain Radiography — 9; 7 Participants
N/A N=8 IDEA Study Cognitive Stimulation Therapy (CST) Trial in Nigeria
Dementia
Primary: World Health Organization Brief Quality of Life Measure (WHOQOL-Bref) — 10.3 units on a scale
N/A N=8 Does Improving Vagal Tone Increase Mitochondrial Bioenergetics
Functional Gastrointestinal Disorders · Irritable Bowel Syndrome · Dyspepsia
Primary: To Measure Different Mitochondrial Bioenergetic Markers, Including Basal Respiratory Capacity — 221.85; 151.14; 139.20 pmol/min
Phase 2 N=36 A Phase I/II Study of [124I]mIBG PET/CT in Neuroblastoma
Metastatic Neuroblastoma
Primary: Comparison of the Number of Lesions Detected as Positive by [123I]mIBG Planar Scintigraphy Which Are Also Considered Positive With [124I]mIBG PET/CT. — 714; 405 Lesions…
Phase 2 N=41 (C2013-0302) Safety and Efficacy of Escalating Doses of SAN-300 in Patients With Rheumatoid Arthritis
Rheumatoid Arthritis
Primary: Number of Participants With Adverse Events — 5; 4; 2; 6 Participants